Company Updates
Emerging Small Caps Summit | Auswide Bank (ASX:ABA) Managing Director Martin Barrett
Learn more about embracing the ‘power of small’ – Auswide Bank (ASX:ABA) Managing Director Martin Barrett will be appearing at the Emerging Small Caps Summit on Friday 4 December
Emerging Small Caps | Lake Resources (ASX:LKE) Managing Director Steve Promnitz
Learn more about developing ‘clean’ lithium projects – Lake Resources (ASX:LKE) Managing Director Steve Promnitz will be appearing at the Emerging Small Caps Summit on Friday 4 December
Emerging Small Caps | neuroCare Founder & Executive Chairman Thomas Mechtersheimer
Learn more about mental health solutions – neuroCare Founder & Executive Chairman Thomas Mechtersheimer will be appearing at the Emerging Small Caps Summit on Friday 4 December
Emerging Small Caps | COG Financial Services (ASX:COG) CEO Andrew Bennett
Learn more about equipment finance broking – COG Financial Services (ASX:COG) CEO Andrew Bennett will be appearing at the Emerging Small Caps Summit on Friday 4 December
Emerging Small Caps | CEO Neil Pollock FirstWave Cloud Technology (ASX:FCT)
Learn more about cyber attacks and solutions – FirstWave Cloud Technology (ASX:FCT) CEO Neil Pollock will be appearing at the Emerging Small Caps Summit on Friday 4 December
Emerging Small Caps | Executive Director, Elementos (ASX:ELT), Chris Dunks
Learn more about advancing tin projects – Elementos (ASX:ELT) Executive Director Chris Dunks will be appearing at the Emerging Small Caps Summit on Friday 4 December | Click here to register for free
Emerging Small Caps | Atrum Coal (ASX:ATU) Managing Director & CEO Andrew Caruso
Learn more about coking coal – Atrum Coal (ASX:ATU) Managing Director & CEO Andrew Caruso will be appearing at the Emerging Small Caps Summit on Friday 4 December | Click here to register for free att
Emerging Small Caps | Crowd Media Holdings Limited (ASX:CM8) CEO Domenic Carosa
Learn more about influencer marketing – Crowd Media Holdings Limited (ASX:CM8) CEO Domenic Carosa will be appearing at the Emerging Small Caps Summit on Friday 4 December
Xerion is building a US prescription drug pipeline of 5 dermatological products and is planning an IPO in late 2021
“Xerion is on an exciting journey developing five prescription solutions to common skin disorders. We offer strong efficacy without the harsh side effects of many of the incumbent prescription
Backed By Leading Investment Groups and Family Offices
